Blockbuster BioTech Move

In one of the largest deals ever in the drug-making industry, Amgen is paying 10-and a-half billion dollars for Onyx Pharmaceuticals. So is this the start of a wave of biotech deals?

Seema Mody reports.

This entry was posted in Health Care. Bookmark the permalink.

Leave a Reply